Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125923962 | 12592396 | 2 | F | 2013 | 20160802 | 20160726 | 20160809 | PER | US-PFIZER INC-2016341926 | PFIZER | 62.00 | YR | F | Y | 82.00000 | KG | 20160809 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125923962 | 12592396 | 1 | PS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | UNK | 21992 | PROLONGED-RELEASE TABLET | ||||||||||
| 125923962 | 12592396 | 2 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 100 MG, UNK | 21992 | 100 | MG | PROLONGED-RELEASE TABLET | ||||||||
| 125923962 | 12592396 | 3 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 50 MG, 1X/DAY | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
| 125923962 | 12592396 | 4 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | UNK | 21992 | PROLONGED-RELEASE TABLET | ||||||||||
| 125923962 | 12592396 | 5 | C | METOPROLOL. | METOPROLOL | 1 | 50 MG, 1X/DAY | 0 | 50 | MG | QD | ||||||||
| 125923962 | 12592396 | 6 | C | METOPROLOL. | METOPROLOL | 1 | 0 | ||||||||||||
| 125923962 | 12592396 | 7 | C | HCTZ | HYDROCHLOROTHIAZIDE | 1 | 25 MG, UNK | 0 | 25 | MG | |||||||||
| 125923962 | 12592396 | 8 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 125923962 | 12592396 | 9 | C | BONIVA | IBANDRONATE SODIUM | 1 | UNK, MONTHLY | 0 | /month | ||||||||||
| 125923962 | 12592396 | 10 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | 5000 IU, UNK | 0 | 5000 | IU | |||||||||
| 125923962 | 12592396 | 11 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | 10000 IU, UNK | 1197114 | 0 | 11000 | IU | ||||||||
| 125923962 | 12592396 | 12 | C | CALCIUM PLUS D3 | 2 | UNK, [CALCIUM 500 MG]/[ COLECALCIFEROL 1000] | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125923962 | 12592396 | 1 | Depression |
| 125923962 | 12592396 | 5 | Blood pressure abnormal |
| 125923962 | 12592396 | 6 | Tachycardia |
| 125923962 | 12592396 | 7 | Blood pressure abnormal |
| 125923962 | 12592396 | 8 | Sleep disorder |
| 125923962 | 12592396 | 9 | Osteopenia |
| 125923962 | 12592396 | 10 | Osteopenia |
| 125923962 | 12592396 | 12 | Osteopenia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125923962 | 12592396 | Crying | |
| 125923962 | 12592396 | Decreased interest | |
| 125923962 | 12592396 | Drug effect incomplete | |
| 125923962 | 12592396 | Intentional product misuse |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125923962 | 12592396 | 3 | 2013 | 0 |